Arcus Biosciences RCUS
NYSE RCUS
$25.88 +0.23 (+0.90%)
As of: Sep 30, 2026 · 3:59 PM EDT

Arcus Biosciences (RCUS) Other financing activities (2022 - 2024)

Updated

Arcus Biosciences (RCUS) reported Other financing activities of $5 million for Q4 2024, up 400.0% from the prior quarter.

Analysis

Arcus Biosciences (RCUS) Other financing activities (2022 - 2024) Analysis & Trends

For FY2024, Arcus Biosciences posted Other financing activities of $7 million.

  • Other financing activities has a three-year compound annual growth rate of 11.9% (FY2021 to FY2024).
  • By year, Other financing activities came in at $10 million in FY2022 (+100.0%) and $5 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Arcus Biosciences 3.26 Bn -77.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 5.00 Mn
Sep 30, 2024 1.00 Mn
Dec 31, 2022 5.00 Mn
Mar 31, 2022 5.00 Mn
API Access

Arcus Biosciences Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=RCUS&period=max&api_key=YOUR_API_KEY